Actively Recruiting
PlaCEUS: Feasibility Study of Contrast-enhanced Ultrasound to Visualize Maternal Uterine Spiral Arteries Postpartum.
Led by Maxima Medical Center · Updated on 2026-02-19
5
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
During pregnancy, unique blood vessels form within the uterine wall, known as spiral arteries. These vessels originate from the uterine artery, which is the main artery supplying blood to the uterus. Throughout pregnancy, spiral arteries undergo significant changes to increase blood and oxygen flow to the placenta, ensuring the developing baby receives adequate nutrients. When these arteries fail to remodel properly, complications such as pre-eclampsia or fetal growth restriction can occur. Until now, direct observation and evaluation of spiral arteries during pregnancy has not been feasible. Contrast-enhanced ultrasound may provide a breakthrough in this area. In this study, the investigators aim to use this imaging technique to visualize spiral arteries after the placenta has been delivered. If successful, this could allow to assess their structural quality. Additionally, the investigators will employ ultrasound to monitor physiological changes in the uterine artery during late pregnancy (after 37 weeks), during labour, and postpartum. By conducting these measurements, the investigators hope to develop methods for detecting spiral artery abnormalities earlier in pregnancy. Early identification could enable timely interventions and help prevent severe complications.
CONDITIONS
Official Title
PlaCEUS: Feasibility Study of Contrast-enhanced Ultrasound to Visualize Maternal Uterine Spiral Arteries Postpartum.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant patient aged 18 years or older
- Singleton pregnancy at term (≥37 weeks gestation)
- Planning to deliver at the Máxima Medical Centre
- Able to provide informed consent
- Intravenous access present at the time of delivery
You will not qualify if you...
- Multiple gestation pregnancy
- Known allergy to SonoVue or its components
- Planning on breastfeeding
- Medical emergency during or after delivery making CEUS impossible or undesirable
- No intravenous access available at the time of delivery
- Body Mass Index greater than 40 kg/m2
- Pre-eclampsia requiring medication
- Fetal growth restriction below the 3rd percentile
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Máxima Medical center
Veldhoven, Netherlands, 5504DB
Actively Recruiting
Research Team
E
Eveline Dekker, Drs
CONTACT
L
Loes Monen, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here